Form 8-K Aravive, Inc. For: Nov 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Aravive Inc. (ARAV) PT Raised to $31 at H.C. Wainwright
November 20, 2019 12:14 PM ESTH.C. Wainwright analyst Joseph Pantginis raised the price target on Aravive Inc. (NASDAQ: ARAV) to $31.00 (from $18.00) while maintaining a Buy rating.
The analyst commented, "This morning, Aravive announced new positive data from the ongoing Phase 1b portion of the Phase 1b/2 clinical trial of... More
Aravive Inc. (ARAV) Halted on LUDP
November 20, 2019 9:46 AM ESTAravive Inc. (NASDAQ: ARAV) Halted on LUDP
... MoreAravive Inc. (ARAV) Extends Gain, Up 250%
November 20, 2019 7:43 AM ESTAravive Inc. (NASDAQ: ARAV) Extends Gain, Up 250%
